Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVY | Common Stock | Options Exercise | $175K | +810 | +10.15% | $216.45 | 8.79K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$46.8K | -216 | -2.46% | $216.45 | 8.57K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $72.9K | +337 | +3.93% | $216.45 | 8.91K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$18K | -83 | -0.93% | $216.45 | 8.83K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $79.2K | +366 | +4.15% | $216.45 | 9.19K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$19.5K | -90 | -0.98% | $216.45 | 9.1K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $74K | +342 | +3.76% | $216.45 | 9.44K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$18.2K | -84 | -0.89% | $216.45 | 9.36K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $414K | +1.91K | +20.42% | $216.45 | 11.3K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$101K | -466 | -4.13% | $216.45 | 10.8K | Mar 1, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVY | 2024 MSU Award | Award | $0 | +1.06K | $0.00 | 1.06K | Mar 1, 2024 | Common Stock | 1.06K | $0.00 | Direct | F1 | |
transaction | AVY | 2024 PU Award | Award | $0 | +1.2K | $0.00 | 1.2K | Mar 1, 2024 | Common Stock | 1.2K | $0.00 | Direct | F2 | |
transaction | AVY | 2020 MSU Award | Options Exercise | $0 | -810 | -100% | $0.00* | 0 | Mar 1, 2024 | Common Stock | 810 | $0.00 | Direct | F3 |
transaction | AVY | 2021 MSU Award | Options Exercise | $0 | -337 | -58.3% | $0.00 | 241 | Mar 1, 2024 | Common Stock | 337 | $0.00 | Direct | F4 |
transaction | AVY | 2022 MSU Award | Options Exercise | $0 | -366 | -32.74% | $0.00 | 752 | Mar 1, 2024 | Common Stock | 366 | $0.00 | Direct | F5 |
transaction | AVY | 2023 MSU Award | Options Exercise | $0 | -342 | -24.91% | $0.00 | 1.03K | Mar 1, 2024 | Common Stock | 342 | $0.00 | Direct | F6 |
transaction | AVY | 2021 PU Award | Options Exercise | $0 | -1.91K | -100% | $0.00* | 0 | Mar 1, 2024 | Common Stock | 1.91K | $0.00 | Direct | F7 |
Id | Content |
---|---|
F1 | Market-leveraged stock units (MSUs) vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on our absolute total stockholder return. Each MSU represents a contingent right to receive one share of common stock, plus dividend equivalents accrued during the vesting period. |
F2 | Performance units (PUs) vest, at the end of fiscal year 2026, provided certain performance objectives are met as determined by the Compensation Committee in February 2027. Each PU represents a contingent right to receive one share of common stock. |
F3 | Shares reflect the vesting of the fourth tranche of MSUs granted in February 2020 at 180% of target based on our absolute total stockholder return in excess of 10% during the 2020-2023 performance period, plus dividend equivalents accrued during the period. |
F4 | Shares reflect the vesting of the third tranche of MSUs granted in March 2021 at 134% of target based on our absolute total stockholder return in excess of 10% during the 2021-2023 performance period, plus dividend equivalents accrued during the period. |
F5 | Shares reflect the vesting of the second tranche of MSUs granted in March 2022 at 94% of target based on our absolute total stockholder return during the 2022-2023 performance period, plus dividend equivalents accrued during the period. |
F6 | Shares reflect the vesting of the first tranche of MSUs granted in March 2023 at 98% of target based on our absolute total stockholder return during the 2023 performance period, plus dividend equivalents accrued during the period. |
F7 | Shares reflect the vesting of PUs granted in March 2021 at 183% of target, based 50% on our cumulative economic value added and 50% on our relative total stockholder return. |